Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (DE:6NQ)
FRANKFURT:6NQ
Holding DE:6NQ?
Track your performance easily

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Stock Price & Analysis

0 Followers

6NQ Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

100.00%
Insiders
― Other Institutional Investors
100.00% Public Companies and
Individual Investors

6NQ FAQ

What was Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s price range in the past 12 months?
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. lowest stock price was €0.63 and its highest was €1.30 in the past 12 months.
    What is Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s market cap?
    Currently, no data Available
    When is Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s earnings last quarter?
    Currently, no data Available
    Is Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. overvalued?
    According to Wall Street analysts Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. pay dividends?
      Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. does not currently pay dividends.
      What is Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s EPS estimate?
      Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. have?
      Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. has 70,770,580 shares outstanding.
        What happened to Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.?
        Currently, no hedge funds are holding shares in DE:6NQ
        ---

        Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Stock Smart Score

        10
        Unlock Smart Score
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Technicals

        SMA
        Negative
        20 days / 200 days
        Momentum
        -12.72%
        12-Months-Change

        Fundamentals

        Return on Equity
        Trailing 12-Months
        Asset Growth
        55.54%
        Trailing 12-Months

        Company Description

        Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.

        Biomed-Lublin Wytwornia Surowic i Szczepionek SA is a pharmaceutical company. The company is engaged in the developing products and therapeutic indications and conducting clinical trials in cooperation with scientific and medical centers. Its products include Prescription drugs, Medical products and Report an adverse reaction.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        DEFAMA Deutsche Fachmarkt AG
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis